Ingevity Corporation
Ingevity Corporation
Your view on NGVT
Overview
What the company does, where it operates, and who runs it.
About Ingevity Corporation
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
- CEO
- David H. Li
- Headquarters
- 4920 O'Hear Avenue, North Charleston, SC, US
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
- CEO
- David H. Li
- Headquarters
- 4920 O'Hear Avenue, North Charleston, SC, US
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals.
The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats.
This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers.
It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide.
This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices.
Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Ingevity Corporation from FRC's valuation model, read against the market price. NGVT last traded at $60.02, 33.8× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Ingevity Corporation. Starting points for Ingevity Corporation: P/E 33.8, EPS $1.74, beta 1.11 — an Chemicals - Specialty name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Ingevity Corporation. Ingevity Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Ingevity Corporation. Trailing twelve-month EPS for Ingevity Corporation stands at $1.74. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$76.67
average of 3 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy10
- Hold3
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $0.87 | $1.21 | $5.39 | $5.96 |
| Low estimate | $0.86 | $1.19 | $5.34 | $5.90 |
| High estimate | $0.88 | $1.22 | $5.45 | $6.03 |
| No. of analysts | 2 | 1 | 2 | 2 |
| Year-ago EPS | $0.58 | $1.15 | -$4.611 | — |
| Growth | +50.6% | +4.8% | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $231.90M | $252.35M | $1.11B | $1.12B |
| Low estimate | $229.94M | $250.22M | $1.10B | $1.11B |
| High estimate | $233.86M | $254.48M | $1.12B | $1.13B |
| No. of analysts | 1 | 1 | 2 | 2 |
| Year-ago revenue | $255.10M | $258.00M | $1.17B | — |
| Growth | -9.1% | -2.2% | -5.2% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Ingevity Corporation. Ingevity Corporation has reported as a listed company since 2016. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- AAUCAllied Gold CorporationGold$2.8B
- ASHAshland Inc.Chemicals - Specialty$3.5B
- CCThe Chemours CompanyChemicals - Specialty$1.9B
- ELVRElevra Lithium LimitedOther Precious Metals$454M
- FMCFMC CorporationAgricultural Inputs$655M
- IOSPInnospec Inc.Chemicals - Specialty$2.0B
- KWRQuaker Chemical CorporationChemicals - Specialty$2.6B
- MTXMinerals Technologies Inc.Chemicals - Specialty$1.9B
More Chemicals - Specialty companies
- VTXPFVictrex plcOTC$740M
- VYSTVystar CorporationOTC$985,264
- WDFCWD-40 CompanyNASDAQ$3.0B
- WKCMFWacker Chemie AGOTC$4.8B
- WLABWhite Label Liquid, Inc.OTC$6,378
- WLKWestlake CorporationNYSE$7.9B
- YIPCFYip's Chemical Holdings LimitedOTC$140M
- YMATJ-Star Holding Co., Ltd. Ordinary SharesNASDAQ$3M
- ZENGZenergy International, Inc.OTC$53,223
- ZEOOFZeon CorporationOTC$1.8B
- ZEOOYZeon CorporationOTC$1.9B
- SEVTSummit Environmental Corporation, Inc.OTC$3,054
ETFs holding Ingevity Corporation
% of the fund
- IJRiShares Core SP Small-Cap ETF$103.8B in assets0.12%
- IWMiShares Russell 2000 ETF$76.6B in assets0.07%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
- VBVanguard Small-Cap ETF$76.9B in assets0.03%
- GSCGoldman Sachs Small Cap Equity ETF$320M in assets1.04%
- XSMOInvesco S&P SmallCap Momentum ETF$2.7B in assets0.44%
- JPSEJPMorgan Diversified Return U.S. Small Cap Equity ETF$575M in assets0.27%
- EESWisdomTree U.S. SmallCap Earnings Fund$688M in assets0.22%
Largest holders first, then the funds most concentrated in NGVT.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Ingevity Corporation, and how their positions are changing. At a $2.03B market value, institutional positions materially move Ingevity Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Ingevity Corporation executives and directors. Shares of Ingevity Corporation have traded between $28.49 and $60.77 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Ingevity Corporation. Coverage tracks Ingevity Corporation within Chemicals - Specialty (Basic Materials). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Ingevity Corporation.